Mark Brunswick Email

SVP Regulatory Affairs . Sorrento Therapeutics

Current Roles

Employees:
247
Revenue:
$21.2M
About
Sorrento Therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. Sorrento's lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical CAR-T therapies targeting solid tumors.
Sorrento Therapeutics Address
4955 Directors Place
San Diego, CA
United States
Sorrento Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.